Biomarkers drive smarter drug development. They reduce uncertainty, de-risk clinical programs, and accelerate timelines by providing quantitative insight into disease biology, target engagement, pharmacodynamics, and patient response. A well-designed biomarker strategy can determine whether a program advances — or fails — early enough to save years of development time and millions in cost.
150+ Off-The-Shelf Assays
-
Inflammation & Cytokines
-
Immuno-oncology
-
Metabolic & Endocrine Markers
-
Cardiovascular & Fibrotic Markers
-
Neurological Biomarkers
-
Kidney & Renal Disease Panels
-
Oncology Panels
-
Custom Multiplex Panels
11 Analysis Platforms
-
Attune™ NxT™
-
CLARIOstar
-
Ella
-
IsoLight
-
Jess
-
Luminex® 200
-
SMCxPRO™
-
Peggy Sue
-
QuickPlex SQ 120
-
QuantStudio™ 6 Pro
-
WES
CLIA-Certified Lab
Through our sister company, SBH Diagnostics, we provide:
- CLIA-certified clinical biomarker testing
- GLP-compliant laboratory operations
- Clinical trial sample processing
- Chain-of-custody and regulatory documentation
- Sample accessioning, storage, and biobanking
- PK/PD biomarker analysis
- Custom clinical biomarker panels
- Flexible sample types: whole blood, serum, plasma, urine, tissue, PBMCs, CSF, cell culture supernatants